This report deals with the synthesis and structural features of tri-and diorganotin(IV) complexes of the general formulae, R n Sn(L) m [n = 3, m = 1, R = Me, n-Bu and Ph; n = 2, m = 2, R = Me, n-Bu, n-Oct and Ph; HL = Schiff base derived from the condensation of 2-aminomethylbenzimidazole (ambmz) and salicylaldehyde (abbreviated as HL or Hsal-ambmz)]. The newly synthesized complexes were characterized by elemental analysis, molar conductance, electronic, infrared, far-infrared, 1 H NMR, 13 C NMR, 119 Sn NMR and 119 Sn Mössbauer spectral studies. Thermal studies of all of the synthesized complexes were also carried out using thermogravimetry-differential thermal analysis-derivative thermogravimetric (TG-DTA-DTG) techniques. The residues thus obtained were characterized by infrared and powder X-ray diffraction analysis. The bioassay results of anti-inflammatory activity (using the carrageenan-induced paw edema bioassay in rats) and acute toxicity (LD 50 ) of the synthesized derivatives indicated that diorganotin(IV) derivatives (19.75-22.23% inhibition) show better activity as compared with triorganotin(IV) derivatives (10.32-17.86% inhibition).